Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

10.33
Delayed Data
As of Jul 01
 +0.09 / +0.88%
Today’s Change
8.27
Today|||52-Week Range
25.25
-35.52%
Year-to-Date
Epizyme Teams Up with Roche's Genentech for Tazemetostat
Jun 23 / Zacks.com - Paid Partner Content
Epizyme Offers Early Data on Non-Hodgkin Lymphoma Drug
Jun 20 / Zacks.com - Paid Partner Content